| Product Code: ETC7623287 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Antimicrobial Resistance Diagnostics Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Antimicrobial Resistance Diagnostics Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Antimicrobial Resistance Diagnostics Market - Industry Life Cycle |
3.4 Ireland Antimicrobial Resistance Diagnostics Market - Porter's Five Forces |
3.5 Ireland Antimicrobial Resistance Diagnostics Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.6 Ireland Antimicrobial Resistance Diagnostics Market Revenues & Volume Share, By Pathogen, 2021 & 2031F |
3.7 Ireland Antimicrobial Resistance Diagnostics Market Revenues & Volume Share, By End-user, 2021 & 2031F |
4 Ireland Antimicrobial Resistance Diagnostics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of infectious diseases in Ireland |
4.2.2 Rising awareness about the importance of early detection and appropriate treatment of antimicrobial resistance |
4.2.3 Government initiatives to combat antimicrobial resistance through diagnostic testing |
4.3 Market Restraints |
4.3.1 High cost associated with antimicrobial resistance diagnostics |
4.3.2 Limited accessibility to advanced diagnostic technologies in certain regions of Ireland |
4.3.3 Lack of skilled healthcare professionals for interpreting diagnostic results accurately |
5 Ireland Antimicrobial Resistance Diagnostics Market Trends |
6 Ireland Antimicrobial Resistance Diagnostics Market, By Types |
6.1 Ireland Antimicrobial Resistance Diagnostics Market, By Technology |
6.1.1 Overview and Analysis |
6.1.2 Ireland Antimicrobial Resistance Diagnostics Market Revenues & Volume, By Technology, 2021- 2031F |
6.1.3 Ireland Antimicrobial Resistance Diagnostics Market Revenues & Volume, By Microbiology Culture, 2021- 2031F |
6.1.4 Ireland Antimicrobial Resistance Diagnostics Market Revenues & Volume, By Immunoassay, 2021- 2031F |
6.1.5 Ireland Antimicrobial Resistance Diagnostics Market Revenues & Volume, By PCR, 2021- 2031F |
6.1.6 Ireland Antimicrobial Resistance Diagnostics Market Revenues & Volume, By NGS, 2021- 2031F |
6.1.7 Ireland Antimicrobial Resistance Diagnostics Market Revenues & Volume, By Mass Spectrometry, 2021- 2031F |
6.1.8 Ireland Antimicrobial Resistance Diagnostics Market Revenues & Volume, By Rapid & Point of Care, 2021- 2031F |
6.2 Ireland Antimicrobial Resistance Diagnostics Market, By Pathogen |
6.2.1 Overview and Analysis |
6.2.2 Ireland Antimicrobial Resistance Diagnostics Market Revenues & Volume, By Drug Resistant Streptococcus Pneumoniae (DRSP), 2021- 2031F |
6.2.3 Ireland Antimicrobial Resistance Diagnostics Market Revenues & Volume, By Drug Resistant Campylobacter (DRC), 2021- 2031F |
6.2.4 Ireland Antimicrobial Resistance Diagnostics Market Revenues & Volume, By Clostridium Difficile (CD), 2021- 2031F |
6.2.5 Ireland Antimicrobial Resistance Diagnostics Market Revenues & Volume, By Methicillin Resistant Staphylococcus Aureus (MRSA), 2021- 2031F |
6.2.6 Ireland Antimicrobial Resistance Diagnostics Market Revenues & Volume, By Drug Resistant Neisseria Gonorrhoeae (DRNG), 2021- 2031F |
6.2.7 Ireland Antimicrobial Resistance Diagnostics Market Revenues & Volume, By Drug Resistant Salmonella (DRNTS), 2021- 2031F |
6.3 Ireland Antimicrobial Resistance Diagnostics Market, By End-user |
6.3.1 Overview and Analysis |
6.3.2 Ireland Antimicrobial Resistance Diagnostics Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 Ireland Antimicrobial Resistance Diagnostics Market Revenues & Volume, By Diagnostic Laboratories, 2021- 2031F |
6.3.4 Ireland Antimicrobial Resistance Diagnostics Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021- 2031F |
6.3.5 Ireland Antimicrobial Resistance Diagnostics Market Revenues & Volume, By Others, 2021- 2031F |
7 Ireland Antimicrobial Resistance Diagnostics Market Import-Export Trade Statistics |
7.1 Ireland Antimicrobial Resistance Diagnostics Market Export to Major Countries |
7.2 Ireland Antimicrobial Resistance Diagnostics Market Imports from Major Countries |
8 Ireland Antimicrobial Resistance Diagnostics Market Key Performance Indicators |
8.1 Percentage increase in the number of healthcare facilities offering antimicrobial resistance diagnostics |
8.2 Number of research and development collaborations between diagnostic companies and healthcare institutions in Ireland |
8.3 Adoption rate of new antimicrobial resistance diagnostic technologies by healthcare providers in Ireland |
9 Ireland Antimicrobial Resistance Diagnostics Market - Opportunity Assessment |
9.1 Ireland Antimicrobial Resistance Diagnostics Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.2 Ireland Antimicrobial Resistance Diagnostics Market Opportunity Assessment, By Pathogen, 2021 & 2031F |
9.3 Ireland Antimicrobial Resistance Diagnostics Market Opportunity Assessment, By End-user, 2021 & 2031F |
10 Ireland Antimicrobial Resistance Diagnostics Market - Competitive Landscape |
10.1 Ireland Antimicrobial Resistance Diagnostics Market Revenue Share, By Companies, 2024 |
10.2 Ireland Antimicrobial Resistance Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here